When.com Web Search

  1. Ads

    related to: drugs that treat hyperkalemia in cats naturally and easily

Search results

  1. Results From The WOW.Com Content Network
  2. Potassium binder - Wikipedia

    en.wikipedia.org/wiki/Potassium_binder

    Potassium binders are medications that bind potassium ions in the gastrointestinal tract, thereby preventing its intestinal absorption. This category formerly consisted solely of polystyrene sulfonate, a polyanionic resin attached to a cation, administered either orally or by retention enema to patients who are at risk of developing hyperkalaemia (abnormal high serum potassium levels).

  3. Polystyrene sulfonate - Wikipedia

    en.wikipedia.org/wiki/Polystyrene_sulfonate

    Polystyrene sulfonates are a group of medications used to treat high blood potassium. [1] Effects generally take hours to days. [1] They are also used to remove potassium, calcium, and sodium from solutions in technical applications. Common side effects include loss of appetite, gastrointestinal upset, constipation, and low blood calcium. [1]

  4. Hyperkalemia - Wikipedia

    en.wikipedia.org/wiki/Hyperkalemia

    Initial treatment in those with ECG changes is salts, such as calcium gluconate or calcium chloride. [1] [3] Other medications used to rapidly reduce blood potassium levels include insulin with dextrose, salbutamol, and sodium bicarbonate. [1] [5] Medications that might worsen the condition should be stopped and a low potassium diet should be ...

  5. Salbutamol - Wikipedia

    en.wikipedia.org/wiki/Salbutamol

    Salbutamol has been used to treat acute hyperkalemia, as it stimulates potassium flow into cells, thus lowering the potassium in the blood. [ 9 ] Two recent studies have suggested that salbutamol reduces the symptoms of newborns and adolescents with myasthenia gravis and transient neonatal myasthenia gravis .

  6. AstraZeneca's Lokelma Gains FDA Nod to Treat Hyperkalemia - AOL

    www.aol.com/news/astrazeneca-apos-lokelma-gains...

    AstraZeneca's (AZN) Lokelma secures an FDA approval for the treatment of hyperkalemia in adults.

  7. Sodium zirconium cyclosilicate - Wikipedia

    en.wikipedia.org/wiki/Sodium_zirconium_cyclosilicate

    In the United States, regulatory approval of ZS-9 was rejected by the Food and Drug Administration (FDA) in May 2016, due to issues associated with manufacturing. [15] On 18 May 2018, the FDA approved sodium zirconium cyclosilicate for treatment of adults with hyperkalemia. [16] It was first practically synthesized by UOP in the late 1990s.